Logotype for Solar Industries India Limited

Solar Industries India (SOLARINDS) Q1 24/25 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Solar Industries India Limited

Q1 24/25 earnings summary

8 Jul, 2026

Executive summary

  • Achieved record quarterly EBITDA of INR 474 crore and PAT of INR 301 crore in Q1 FY25, with turnover at INR 1,695 crore, up 5% sequentially from Q4 FY24.

  • EBITDA and PAT margins reached all-time highs at 28% and 18%, respectively.

  • Domestic explosives volume grew 16% year-over-year, aligning with annual guidance.

  • Defense revenue rose 32% year-over-year to INR 204 crore, with strong order book and new product deliveries.

  • Unaudited standalone and consolidated financial results for the quarter ended June 30, 2024, were approved by the Board and reviewed by auditors, with no material misstatements identified.

Financial highlights

  • Revenue for Q1 FY25 was INR 1,695 crore, up from INR 1,682 crore year-over-year.

  • EBITDA increased 43% year-over-year to INR 474 crore.

  • PBT rose 50% year-over-year to INR 408 crore; PAT up 49% to INR 301 crore.

  • Export and overseas revenue at INR 579 crore, representing 34% of total revenue.

  • Basic and diluted EPS (consolidated) for the quarter was ₹31.66, up from ₹25.98 in the previous quarter and ₹21.82 year-over-year.

Outlook and guidance

  • Defense revenue guidance for FY25 set at INR 1,500 crore, with expectations to comfortably achieve this.

  • EBITDA margin guidance for FY25 raised to around 25%, up from previous 23%+.

  • Acquisition of 73.99% stake in Problast BS Pty (LLP), South Africa, expected to complete by December 2025, indicating expansion plans.

  • Anticipates continued growth in defense, infrastructure, and international markets.

  • No major fluctuations expected in ammonium nitrate prices.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more